Company Filing History:
Years Active: 2017
Title: Innovator in Cystic Fibrosis Research: Hai Miao from Winchester, MA
Introduction: Hai Miao, an accomplished inventor based in Winchester, Massachusetts, has made significant strides in the field of pharmaceutical innovation. With a focus on the treatment of cystic fibrosis, his work contributes to advancing medical science and improving patient outcomes.
Latest Patents: Hai Miao holds a patent for "Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator." This patent involves co-crystals that comprise N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1) combined with a co-former and outlines methods for their preparation. Additionally, it discusses pharmaceutical compositions based on these co-crystal forms, as well as methods of treatment and kits for their use.
Career Highlights: Hai Miao is currently affiliated with Vertex Pharmaceuticals, Inc., a leading biotechnology company known for its innovative therapies. His work contributes to the development of cutting-edge treatments, enhancing the lives of those affected by cystic fibrosis and other serious diseases.
Collaborations: Throughout his career, Miao has collaborated with fellow researchers and industry experts, including notable colleagues like Mark Strohmeier and John P. Caesar, Jr. These collaborations foster an environment of shared knowledge and innovation, driving the momentum in pharmaceutical research.
Conclusion: Hai Miao exemplifies the spirit of innovation in the pharmaceutical industry. His contributions not only reflect his dedication to research but also stand to potentially transform treatment methods for cystic fibrosis. As healthcare continues to evolve, the impact of inventors like Miao will be felt for generations to come.